NDC 44278-025

Exemestane

Exemestane

Exemestane is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eirgen Pharma Ltd. The primary component is Exemestane.

Product ID44278-025_89a3ed4e-4c07-4e19-e053-2995a90a65ee
NDC44278-025
Product TypeHuman Prescription Drug
Proprietary NameExemestane
Generic NameExemestane
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-05-22
Marketing CategoryANDA / ANDA
Application NumberANDA200898
Labeler NameEirgen Pharma Ltd
Substance NameEXEMESTANE
Active Ingredient Strength25 mg/1
Pharm ClassesAromatase Inhibitor [EPC],Aromatase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 44278-025-30

30 TABLET in 1 BOTTLE (44278-025-30)
Marketing Start Date2013-11-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 44278-025-30 [44278002530]

Exemestane TABLET
Marketing CategoryANDA
Application NumberANDA200898
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-11-22

Drug Details

Active Ingredients

IngredientStrength
EXEMESTANE25 mg/1

OpenFDA Data

SPL SET ID:88fb6543-383b-4195-a2c1-2673ac194f4b
Manufacturer
UNII
UPC Code
  • 0347781108304
  • Pharmacological Class

    • Aromatase Inhibitor [EPC]
    • Aromatase Inhibitors [MoA]

    NDC Crossover Matching brand name "Exemestane" or generic name "Exemestane"

    NDCBrand NameGeneric Name
    0054-0080ExemestaneExemestane
    0378-5001Exemestaneexemestane
    0832-0595ExemestaneExemestane
    44278-025ExemestaneEXEMESTANE
    47781-108ExemestaneExemestane
    50090-5193ExemestaneExemestane
    51991-005ExemestaneExemestane
    59651-516ExemestaneExemestane
    59762-2858EXEMESTANEExemestane
    63629-2056ExemestaneExemestane
    65162-240ExemestaneExemestane
    68382-383ExemestaneExemestane
    69097-316EXEMESTANEexemestane
    70771-1374ExemestaneExemestane
    71921-190ExemestaneExemestane
    0009-7663Aromasinexemestane

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.